Dermatomyositis-like rash and inflammatory myopathy after mRNA-1273 vaccination.

Kondo, Yasushi; Oyama, Munenori; Nakamura, Yoshio; Matsubara, Shiro; Tanikawa, Akiko; Kaneko, Yuko

Kondo, Yasushi; Oyama, Munenori; Nakamura, Yoshio; Matsubara, Shiro; Tanikawa, Akiko; Kaneko, Yuko.

Kondo Y; Division of Rheumatology.
Oyama M; Division of Neurology, Department of Internal Medicine, Keio University School of Medicine.
Nakamura Y; Department of Neurology and Department of Neuropathology, Tokyo Metropolitan Neurological Hospital.
Matsubara S; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Tanikawa A; Department of Neurology and Department of Neuropathology, Tokyo Metropolitan Neurological Hospital.
Kaneko Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Rheumatology (Oxford) ; 61(7): e171-e173, 2022 07 06.

Article in English | MEDLINE | ID: covidwho-1628762

Subject(s)

2019-nCoV Vaccine mRNA-1273; Dermatomyositis; Exanthema; Myositis; 2019-nCoV Vaccine mRNA-1273/adverse effects; Dermatomyositis/etiology; Exanthema/chemically induced; Humans; Myositis/chemically induced; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dermatomyositis / Exanthema / 2019-nCoV Vaccine mRNA-1273 / Myositis Topics: Vaccines Limits: Humans Language: English Journal: Rheumatology (Oxford) Journal subject: Rheumatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google